Control: Resonant Announced by Remedy for 2026 Release | The Game Awards 2025

Remedy Entertainment unveiled Control: Resonant at the 2025 Game Awards, a 2026 release for PC, PS5 and Xbox Series X|S that shifts the franchise seven years forward and swaps protagonist Jesse Faden for her younger brother Dylan as the Hiss spreads from the Oldest House into Manhattan. The studio is moving away from Jesse’s ranged Service Weapon to a close‑quarters, transforming melee weapon called the Aberrant, pairing nimble, movement‑driven combat with supernatural abilities, deep build customization, progression systems, side quests and competing factions; Remedy says the game is accessible to newcomers. Positioned as “not a safe sequel,” the creative pivot is intended to broaden the series’ gameplay identity but represents a strategic risk that could materially affect reception and commercial performance for the franchise.

Analysis

Remedy Entertainment announced Control: Resonant at the 2025 Game Awards with a 2026 release window for PC, PS5 and Xbox Series X|S; the title advances the timeline seven years and shifts the protagonist from Jesse Faden to her younger brother Dylan while the Hiss spreads from the Oldest House into Manhattan. The studio positions the game as a deliberate departure rather than a direct sequel, explicitly saying it is “not a safe sequel,” and emphasizes accessibility for players who have not played the original.

Gameplay changes are material: Remedy replaces Jesse’s ranged, transforming Service Weapon with a close-quarters transforming melee called the Aberrant and highlights a movement‑driven, push‑forward combat loop that combines weapon combos with supernatural abilities, customizable builds, progression systems, side quests and competing factions; creative director Mikael Kasurinen framed combat as “fast, proactive” and tactically focused. Early commentary likens the feel to action-adventure combat (the article compares it to Respawn’s Jedi titles), which signals a conscious genre pivot intended to broaden appeal.

From a market perspective, available signals are mildly positive (sentiment_score 0.25) with low immediate market impact (market_impact_score 0.12), which implies the announcement is informative but not market-moving absent further commercial indicators. The commercial outcome will depend on early critical reception, player engagement with the new combat loop and demonstration of monetization or retention hooks ahead of the 2026 launch.

Key Decisions for Investors

• Monitor early engagement indicators—trailer viewership, preview coverage, beta/demo feedback and pre-order momentum—as primary signals of commercial acceptance
• Limit or hedge near-term exposure to Remedy or related suppliers until hands‑on previews validate the combat pivot and build/progression systems, given the studio’s explicit "not a safe sequel" stance
• Consider adding selective exposure opportunistically if independent previews and early customer metrics are strongly positive, since a successful pivot could broaden the franchise audience ahead of the 2026 launch
• Track subsequent announcements on monetization, release timing and platform sales guidance at major events as key catalysts that will materially change the investment thesis